Health Care

What Analyst Suggest Today? Mylan N.V. (NASDAQ:MYL)

0 6

Mylan N.V. (NASDAQ:MYL) surged +0.72% and closed the trade at $ 41.79. The company recorded a trading capacity of 8.75 million shares above its three months average daily volume of 5.65 million shares. During the last trade, shares reached to high price of $41.86 and touched the low price of $40.93. The stock’s 50-day moving average is noted at $45.44 and its 200-day moving average is stands at $44.94.

Additionally, the company has a PE ratio of 26.45 and has EPS of 1.58. The company has market capitalization of $22.35B.

Currently Mylan N.V. (MYL) captured an average recommendation of “ Overweight ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “10″ Analysts”. “0” rated “Sell” for the company. “7” said the company as a “Hold”. Overweight rating was given by “2” and Underweight rating was given by “0”.

Analysts are expecting that the company to achieve $57.27 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $66.00 however minimum price target advised by analysts is $48.00. The Median price target for the stock is measured at $59.00.

Presently, Analysts decided consensus EPS estimate of $1.57 for present quarter and one month ago projected EPS estimate was at $1.58. If we take a look at back 3 month ago, consensus EPS estimate was $1.56.

A current consensus EPS estimate for next quarter is at $1.45 and 3 month ago EPS forecast was $1.46. Have a look at back 1 month ago, consensus EPS forecast was seen at $1.47.

For current fiscal year, most recent EPS estimate is set at $4.96 based on Analyst consensus and three month ago consensus EPS opinions was at $4.93. During period one month ago, consensus EPS forecast was decided at $4.98.

A current consensus EPS projection for next fiscal year is observed at $5.75 and one month ago consensus EPS forecast was at $5.81. Take a look at back three month ago, consensus EPS estimate opinions was decided at $5.69 by analysts.

One Month ago, the stock has gained consensus mean rating of Overweight based on the analysis of brokerage analyst firms polled. 10 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 2. 8 advised the “Hold” rating about this stock. 0 revealed “Sell” signal and “Underweight” rating was declared by 0.

Three Months Ago, Analysts recommended an average brokerage rating of Overweight derived from brokerage firms, according to FactSet. 10 said a “Buy Rating” and 2 announced “Overweight Rating”. 9 advised “Hold Rating” regarding the stock. 0 announced “Sell Rating” and 0 disclosed “Underweight Rating”.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter